USPTO 2015–2025 USPTO PatentsView US Corporation

Inovio Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 84 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Inovio ranks #4,246 of 49,997 tracked US assignees by granted-patent volume, with 84 patents across 18 technology areas.

#4,246
of 49,997 US assignees by volume
Top 14%
by Innovation Score (50.1/100)
16.0
avg claims per patent
+176%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4246 · US Corporation #4,246 · 84 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 84 grants
  • TOP-DECILE #4,246/49,997
  • PHOTO-FINISH Galapagos
  • CPC-FOCUS A61K · 18 areas
  • INNOV-PAR 50.1/100
  • CLAIMS-RICH 16.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +176% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Galapagos NV (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Inovio

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Inovio's Innovation Score is 50.1/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Inovio's grants concentrate

Inovio Pharmaceuticals, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 83.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (17 grants) versus a trough of 1 in 2017. By volume, Inovio sits between Galapagos NV and Mallinckrodt Hospital Products IP Unlimited Company.

Inovio's three-year grant acceleration

From 2019–2021 to 2022–2024, Inovio Pharmaceuticals, Inc. moved from 25 to 38 grants (1.52x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Inovio's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Inovio holds 84 patents at rank #4,246, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Inovio

By rank, the assignees closest to #4,246 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Inovio's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Inovio, neither rank-band nor same-CPC leaders (those blocks stay above).

Inovio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Inovio Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 6.0%
2016 3 3.6%
2017 1 1.2%
2018 7 8.3%
2019 5 6.0%
2020 3 3.6%
2021 17 20.2%
2022 10 11.9%
2023 12 14.3%
2024 16 19.0%
2025partial year 5 6.0%

Which technologies does Inovio Pharmaceuticals, Inc. patent most?

Top 15 of 18 technology areas

Where it ranks

Overall rank by patents

#4,246

of 49,997 tracked assignees

Innovation Score

50.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Inovio Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

  • Inovio Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 83.3% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #4,246 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Inovio Pharmaceuticals, Inc. against Galapagos NV, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 50.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.